Literature DB >> 9544870

Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control.

L A Weinrauch1, F P Kennedy, R E Gleason, J Keough, J A D'Elia.   

Abstract

The objective of this study was to test the relationship between neurologic and microvascular complications of type 1 diabetes mellitus. It was hypothesized that the mechanisms operative in autonomic dysfunction seen in diabetic patients with microangiopathy play a role in the rapidity of progression to renal failure. Twenty-six type 1 diabetic patients with proteinuria were studied with computerized monitoring of heart rate variation during timed ventilation, assumption of upright posture, and Valsalva maneuver and with 24-h ambulatory blood pressure monitoring at baseline. Renal function was evaluated over the ensuing 12 months of intensive insulin therapy. Blood pressure was treated so as to achieve consistent 24-h readings < 140/90 mm Hg. Angiotensin converting enzyme inhibitors were the preferred antihypertensive agents. Serial serum creatinine concentrations were compared using repeated measures analysis of variance. Over 12 months there were no significant serum creatinine changes for any autonomic test group with normal results at baseline. Groups with abnormal autonomic results at baseline demonstrated statistically significant increases in serum creatinine over 12 months compared to their baseline. Of the tests, Valsalva separated groups of patients with similar degrees of baseline renal impairment. Each of the sympathetic plus Valsalva combinations demonstrated a significant difference in progression of serum creatinine increase over 12 months. In each instance, if both sympathetic and Valsalva results were abnormal, there was a statistically significant increase in serum creatinine over 12 months when compared to groups in which one or both test results were normal. There is a relationship between autonomic function and the progression of renal dysfunction. The inability to vary the heart rate to a Valsalva maneuver identifies a degree of parasympathetic dysfunction that permits unopposed sympathetic tone, heralding more rapid renal destruction. A simple inexpensive bedside laboratory test discerned a relatively low-risk group of diabetic patients with proteinuria that demonstrated no deterioration in renal function over 12 months. When the Valsalva maneuver was markedly abnormal the presence of a mean arterial pressure > 100 mm Hg was associated with a greater likelihood of rapid renal deterioration. This group at higher risk of renal deterioration should undergo aggressive lowering of mean arterial blood pressure to < 95 mm Hg.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544870     DOI: 10.1016/s0895-7061(97)00472-x

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

Review 1.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Predictors of heart rate variability and its prognostic significance in chronic kidney disease.

Authors:  Preeti Chandra; Robin L Sands; Brenda W Gillespie; Nathan W Levin; Peter Kotanko; Margaret Kiser; Fredric Finkelstein; Alan Hinderliter; Rodica Pop-Busui; Sanjay Rajagopalan; Rajiv Saran
Journal:  Nephrol Dial Transplant       Date:  2011-09-12       Impact factor: 5.992

3.  Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.

Authors:  M Ino; T Yoshinaga; M Wakamori; N Miyamoto; E Takahashi; J Sonoda; T Kagaya; T Oki; T Nagasu; Y Nishizawa; I Tanaka; K Imoto; S Aizawa; S Koch; A Schwartz; T Niidome; K Sawada; Y Mori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

4.  Importance of blood pressure reduction for prevention of progression of renal disease.

Authors:  S C Textor; V J Canzanello
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

Review 5.  The Diabetic Cardiorenal Nexus.

Authors:  John A D'Elia; George P Bayliss; Larry A Weinrauch
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 6.  Diabetes and cardiovascular autonomic dysfunction: application of animal models.

Authors:  Katia De Angelis; Maria Claudia Irigoyen; Mariana Morris
Journal:  Auton Neurosci       Date:  2008-12-02       Impact factor: 3.145

7.  Chromogranin A polymorphisms are associated with hypertensive renal disease.

Authors:  Rany M Salem; Peter E Cadman; Yuqing Chen; Fangwen Rao; Gen Wen; Bruce A Hamilton; Brinda K Rana; Douglas W Smith; Mats Stridsberg; Harry J Ward; Manjula Mahata; Sushi K Mahata; Donald W Bowden; Pamela J Hicks; Barry I Freedman; Nicholas J Schork; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

8.  Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes.

Authors:  Kevin M Wheelock; Mamta Jaiswal; Catherine L Martin; Gudeta D Fufaa; E Jennifer Weil; Kevin V Lemley; Berne Yee; Eva Feldman; Frank C Brosius; William C Knowler; Robert G Nelson; Rodica Pop-Busui
Journal:  J Diabetes Complications       Date:  2016-03-11       Impact factor: 2.852

9.  Left ventricular mass reduction in type 1 diabetic patients with nephropathy.

Authors:  Larry A Weinrauch; Andrew Burger; Ray E Gleason; Annette T Lee; John A D'Elia
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-03       Impact factor: 3.738

10.  Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus.

Authors:  Yong Kyun Kim; Jung Eun Lee; Yoon Goo Kim; Dae Joong Kim; Ha-Young Oh; Chul Woo Yang; Kwang-Won Kim; Wooseong Huh
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.